Krka, d. d. (LJSE:KRKG)

Market Cap	5.21B
Revenue (ttm)	1.90B
Net Income (ttm)	359.83M
Shares Out	30.75M
EPS (ttm)	11.67
PE Ratio	14.53
Forward PE	15.04
Dividend	7.50 (4.45%)
Ex-Dividend Date	Jul 23, 2024

Volume	7,184
Average Volume	8,504
Open	169.50
Previous Close	170.00
Day's Range	168.00 - 171.50
52-Week Range	119.00 - 171.50
Beta	0.53
RSI	72.71
Earnings Date	Apr 10, 2025

About Krka, d. d.

Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. Its prescription pharmaceuticals include medicines for the treatment of cardiovascular, alimentary tract and metabolism, central nervous system, infections, oncology, and other diseases. The company provides non-prescription products for oral cavity and pharynx; cough and cold; analge...

• Industry: Pharmaceutical Preparations
• Founded: 1954
• Employees: 10,284
• Stock Exchange: Ljubljana Stock Exchange
• Ticker Symbol: KRKG

Financial Performance

In 2023, Krka, d. d.'s revenue was 1.81 billion, an increase of 5.18% compared to the previous year's 1.72 billion. Earnings were 313.95 million, a decrease of -13.58%.